Skip to main content
Petter Bjornstad, MD, Pediatric Endocrinology, Seattle, WA

Petter Bjornstad MD


resident

Join to View Full Profile
  • 1959 NE Pacific StSeattle, WA 98195

  • Phone+1 206-520-5000

Dr. Bjornstad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Pediatric Endocrinology, 2015 - 2018
  • University of Colorado
    University of ColoradoResidency, Pediatrics, 2012 - 2015
  • Royal College of Surgeons Ireland
    Royal College of Surgeons IrelandClass of 2010

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2023 - 2026
  • CO State Medical License
    CO State Medical License 2015 - 2025
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Endocrinology
    American Board of Pediatrics Pediatric Endocrinology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • M36R. Youth-onset Type 2 Diabetes (Repeat) 
    ENDO 2019 - New Orleans, LA - 3/25/2019
  • Youth-onset Type 2 Diabetes 
    ENDO 2019 - New Orleans, LA - 3/25/2019

Authored Content

  • ADA 2018: Dr. Petter Bjornstad on Adioposity, Insulin Resistance and Type 2 Diabetes MellitusJuly 2018
  • ADA 2018: Dr. Petter Bjornstad on Adioposity, Insulin Resistance and Type 2 Diabetes MellitusJuly 2018
  • Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth with Type 2 DiabetesJune 2018

Press Mentions

  • Parkinson's Medication Improved Blood Pressure in Teens with Type 1 Diabetes
    Parkinson's Medication Improved Blood Pressure in Teens with Type 1 DiabetesDecember 6th, 2022
  • CU School of Medicine Researcher Brews up Study on Coffee’s Effects on Acute Kidney Injury
    CU School of Medicine Researcher Brews up Study on Coffee’s Effects on Acute Kidney InjurySeptember 23rd, 2022
  • SGLT2 Inhibitors Breathe Life into Kidney-Disease Care
    SGLT2 Inhibitors Breathe Life into Kidney-Disease CareAugust 10th, 2022
  • Join now to see all

Grant Support

  • Advancing ADPKD Treatment with GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and MechanismUNIVERSITY OF COLORADO DENVER2024–2029
  • Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant RecipientsUNIVERSITY OF COLORADO DENVER2023–2028
  • Immunometabolism and the Cardio-Renal Axis in T1D-associated Atherosclerosis: Insights from the CaRe T1D BiobankUNIVERSITY OF WASHINGTON2024–2027
  • Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohortUNIVERSITY OF WASHINGTON2022–2027
  • Puberty, diabetes, and the kidneys, when eustress becomes distressSEATTLE CHILDREN'S HOSPITAL2024–2026
  • Puberty, diabetes, and the kidneys, when eustress becomes distressSEATTLE CHILDREN'S HOSPITAL2024–2026
  • Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)UNIVERSITY OF COLORADO DENVER2022–2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: